142 related articles for article (PubMed ID: 1928036)
21. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
[TBL] [Abstract][Full Text] [Related]
22. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease.
Fotherby KJ; Wraight EP; Neale G
Scand J Gastroenterol; 1988 Mar; 23(2):171-7. PubMed ID: 3129775
[TBL] [Abstract][Full Text] [Related]
23. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
24. Water absorption enhances the uptake of mannitol and decreases Cr-EDTA/mannitol permeability ratios in cat small intestine in situ.
Bijlsma PB; Fihn BM; Sjöqvist A; Groot JA; Taminiau JA; Jodal M
Scand J Gastroenterol; 2002 Jul; 37(7):799-806. PubMed ID: 12190093
[TBL] [Abstract][Full Text] [Related]
25. Application of the 51Cr-EDTA urinary recovery test for assessment of intestinal permeability in the horse.
Escala J; Gatherer ME; Voûte L; Love S
Res Vet Sci; 2006 Apr; 80(2):181-5. PubMed ID: 16143355
[TBL] [Abstract][Full Text] [Related]
26. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease.
O'Morain CA; Abelow AC; Chervu LR; Fleischner GM; Das KM
J Lab Clin Med; 1986 Nov; 108(5):430-5. PubMed ID: 3095471
[TBL] [Abstract][Full Text] [Related]
27. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change.
Jenkins AP; Nukajam WS; Menzies IS; Creamer B
Scand J Gastroenterol; 1992 Sep; 27(9):769-73. PubMed ID: 1411284
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects.
Blomquist L; Bark T; Hedenborg G; Svenberg T; Norman A
Scand J Gastroenterol; 1993 Mar; 28(3):274-80. PubMed ID: 8446853
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability.
Blomquist L; Bark T; Hedenborg G; Norman A
Scand J Gastroenterol; 1997 Aug; 32(8):805-12. PubMed ID: 9282973
[TBL] [Abstract][Full Text] [Related]
34. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease.
Bjarnason I; Maxton D; Reynolds AP; Catt S; Peters TJ; Menzies IS
Scand J Gastroenterol; 1994 Jul; 29(7):630-9. PubMed ID: 7939400
[TBL] [Abstract][Full Text] [Related]
35. Intestinal permeability in patients with Crohn's disease and their healthy relatives.
Katz KD; Hollander D; Vadheim CM; McElree C; Delahunty T; Dadufalza VD; Krugliak P; Rotter JI
Gastroenterology; 1989 Oct; 97(4):927-31. PubMed ID: 2506103
[TBL] [Abstract][Full Text] [Related]
36. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability.
Maxton DG; Bjarnason I; Reynolds AP; Catt SD; Peters TJ; Menzies IS
Clin Sci (Lond); 1986 Jul; 71(1):71-80. PubMed ID: 3086024
[TBL] [Abstract][Full Text] [Related]
37. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives.
Ainsworth M; Eriksen J; Rasmussen JW; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1989 Oct; 24(8):993-8. PubMed ID: 2512633
[TBL] [Abstract][Full Text] [Related]
38. Urinary recovery of orally administered chromium 51-labeled EDTA, lactulose, rhamnose, d-xylose, 3-O-methyl-d-glucose, and sucrose in healthy adult male Beagles.
Frias R; Steiner JM; Williams DA; Sankari S; Westermarck E
Am J Vet Res; 2012 May; 73(5):654-8. PubMed ID: 22533396
[TBL] [Abstract][Full Text] [Related]
39. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
[TBL] [Abstract][Full Text] [Related]
40. Intestinal permeability to [51Cr]EDTA in children with Crohn's disease and celiac disease.
Turck D; Ythier H; Maquet E; Deveaux M; Marchandise X; Farriaux JP; Fontaine G
J Pediatr Gastroenterol Nutr; 1987; 6(4):535-7. PubMed ID: 3123634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
